These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 27555555
21. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy. Whitehead NP, Bible KL, Kim MJ, Odom GL, Adams ME, Froehner SC. J Physiol; 2016 Dec 15; 594(24):7215-7227. PubMed ID: 27570057 [Abstract] [Full Text] [Related]
26. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Gehrig SM, van der Poel C, Sayer TA, Schertzer JD, Henstridge DC, Church JE, Lamon S, Russell AP, Davies KE, Febbraio MA, Lynch GS. Nature; 2012 Apr 04; 484(7394):394-8. PubMed ID: 22495301 [Abstract] [Full Text] [Related]
27. Electrical impedance myography detects dystrophin-related muscle changes in mdx mice. Hiyoshi T, Zhao F, Baba R, Hirakawa T, Kuboki R, Suzuki K, Tomimatsu Y, O'Donnell P, Han S, Zach N, Nakashima M. Skelet Muscle; 2023 Nov 18; 13(1):19. PubMed ID: 37980539 [Abstract] [Full Text] [Related]
28. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points. Capogrosso RF, Mantuano P, Cozzoli A, Sanarica F, Massari AM, Conte E, Fonzino A, Giustino A, Rolland JF, Quaranta A, De Bellis M, Camerino GM, Grange RW, De Luca A. J Appl Physiol (1985); 2017 Apr 01; 122(4):828-843. PubMed ID: 28057817 [Abstract] [Full Text] [Related]
31. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways. Sadler KJ, Gatta PAD, Naim T, Wallace MA, Lee A, Zaw T, Lindsay A, Chung RS, Bello L, Pegoraro E, Lamon S, Lynch GS, Russell AP. Exp Physiol; 2021 Jul 01; 106(7):1597-1611. PubMed ID: 33963617 [Abstract] [Full Text] [Related]
32. The location of protein oxidation in dystrophic skeletal muscle from the mdx mouse model of Duchenne muscular dystrophy. Iwasaki T, Terrill JR, Kawarai K, Miyata Y, Tagami T, Maeda N, Hasegawa Y, Watanabe T, Grounds MD, Arthur PG. Acta Histochem; 2022 Dec 01; 124(8):151959. PubMed ID: 36270048 [Abstract] [Full Text] [Related]
34. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy. Pinniger GJ, Terrill JR, Assan EB, Grounds MD, Arthur PG. J Physiol; 2017 Dec 01; 595(23):7093-7107. PubMed ID: 28887840 [Abstract] [Full Text] [Related]
35. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD. Guiraud S, Edwards B, Squire SE, Moir L, Berg A, Babbs A, Ramadan N, Wood MJ, Davies KE. Hum Mol Genet; 2019 Jan 15; 28(2):307-319. PubMed ID: 30304405 [Abstract] [Full Text] [Related]
38. Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice. Schertzer JD, van der Poel C, Shavlakadze T, Grounds MD, Lynch GS. Am J Physiol Cell Physiol; 2008 Jan 15; 294(1):C161-8. PubMed ID: 17989207 [Abstract] [Full Text] [Related]
39. Postdevelopmental knockout of Orai1 improves muscle pathology in a mouse model of Duchenne muscular dystrophy. García-Castañeda M, Michelucci A, Zhao N, Malik S, Dirksen RT. J Gen Physiol; 2022 Sep 05; 154(9):. PubMed ID: 35939054 [Abstract] [Full Text] [Related]
40. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice. Bronisz-Budzyńska I, Chwalenia K, Mucha O, Podkalicka P, Karolina-Bukowska-Strakova, Józkowicz A, Łoboda A, Kozakowska M, Dulak J. Skelet Muscle; 2019 Aug 14; 9(1):22. PubMed ID: 31412923 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]